Ricovir-L - Tenofovir Disoproxil Fumarate, Lamivudine Tabs

Tenofovir Disoproxil Fumarate and Lamivudine both belong to a class of antiretroviral drugs known as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), which work by interfering with an enzyme HIV needs to replicate its genetic material. When combined, these two medications target viral replication through complementary mechanisms, helping to more effectively lower the amount of virus in the blood. This reduction in viral load allows the immune system a better opportunity to recover, often reflected in improved CD4 cell counts over time. The combination is typically used alongside a third antiretroviral agent, such as an NNRTI or protease inhibitor, as part of a complete highly active antiretroviral therapy (HAART) regimen. It is generally taken orally on a consistent daily schedule, and adherence to the prescribed routine is important for maintaining viral suppression and reducing the risk of resistance. Regular monitoring, including blood tests to check viral load, CD4 counts, and kidney function, is typically recommended throughout treatment. Many patients on this combination achieve meaningful and sustained control of HIV infection with consistent use. As with all antiretroviral therapies, treatment should be guided by a healthcare provider familiar with the patient's overall health and treatment history.